StonvexLoading…
StonvexStonvexStonvexCore line items from MORN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $644.80M | $2.45B | $1.80B | $1.19B |
Operating Income | $155.90M | $526.60M | $367.00M | $239.20M |
Net Income | $107.10M | $374.20M | $259.10M | $89.00M |
EPS (Diluted) | $2.73 | $8.87 | $6.08 | $3.91 |
Total Assets | $3.99B | $3.59B | $3.56B | $3.63B |
Total Liabilities | $2.97B | $2.37B | $2.04B | $2.02B |
Cash & Equivalents | $492.80M | $474.50M | $474.20M | $503.50M |
Free Cash Flow OCF − CapEx | $53.60M | $442.60M | $281.30M | $121.20M |
Shares Outstanding | 38.03M | 39.74M | 41.51M | 42.18M |